Electronic cigarette use and its association with asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome among never cigarette smokers.

Emine Bircan,Pebbles Fagan,Austin Porter,Mohammed Orloff,Ummugul Bezirhan

doi:10.18332/tid/132833

Abstract

INTRODUCTIONAlthough smoking is a strong risk factor for lung diseases including asthma, COPD, and asthma-COPD overlap syndrome (ACOS), studies are needed to examine the association between e-cigarettes and asthma, COPD, and ACOS. This study evaluated the association between e-cigarette use and self-reported diagnosis of asthma, COPD, and ACOS using a large nationally representative sample of adults aged ≥18 years in the United States.METHODSCross-sectional data from the Behavioral Risk Factor Surveillance System (BRFSS) from 2016 to 2018 was used to examine self-reported information on current e-cigarette use, demographic variables, and asthma and COPD status among never cigarette smokers (n=8736). Asthma and COPD were measured by self-reported diagnosis, and respondents who reported having both diagnoses were then classified as having ACOS. Of the 46079 never cigarette smokers, 4368 non-e-cigarette smokers were 1:1 propensity score-matched to e-cigarette smokers on age, sex, race/ethnicity and education level. We used multinomial logistic regression to examine association between current e-cigarette use and self-report asthma, COPD, and ACOS while controlling for marital status and employment in addition to matching variables.RESULTSCompared with never e-cigarette smokers, e-cigarette smokers had increased odds of self-reported ACOS (OR=2.27; 95% CI: 2.23–2.31), asthma (OR=1.26; 95% CI: 1.25–1.27) and COPD (OR=1.44; 95% CI: 1.42–1.46).CONCLUSIONSData from this large nationally representative sample suggest that e-cigarette use is associated with increased odds of self-reported asthma, COPD, and ACOS among never combustible cigarette smokers. The odds of ACOS were twice as high among e-cigarette users compared with never smokers of conventional cigarettes. The findings from this study suggest the need to further investigate the long-term and short-term health effects of e-cigarette use, since the age of those at risk in our study was 18–24 years.

Highlights

Study Protocols consist of Introduction, Methods, Discussion, and Conclusions
Papers should consist of Introduction, Methodological approach, Case studies or practical examples, Discussion, Conclusions
TID adheres to the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Summary

Methodology Papers

Papers that present different methodological approaches that can be used to investigate problems in a relevant scientific field and to encourage innovation. Letters intended for publication should be a maximum of 500 words, contain 10 references, and up to one table or figure. These rules apply both for research letters, and letters that respond to articles published in the journal. TID warmly encourages the submission of guest editorials by organizations working in tobacco control that wish to present their work to the scientific community in the form of an editorial. These may be accompanied by videos, who reports or other dissemination material produced by the organizations. It should not include rhetorical questions, literary language, quotations and special symbols

Main text

Declaration of interests